Natixis Advisors
CHE icon

Natixis Advisors’s Chemed CHE Stock Holding History

Natixis Advisors’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-58,006
Closed -$33.9M – 1534
2023
Q4 		$33.9M Sell
58,006
-19,134
-25% -$10.7M 0.09% 243
2023
Q3 		$40.1M Buy
77,140
+4,763
+7% +$2.48M 0.12% 194
2023
Q2 		$39.2M Buy
72,377
+13,293
+22% +$7.27M 0.12% 190
2023
Q1 		$31.8M Buy
59,084
+5,369
+10% +$2.74M 0.11% 210
2022
Q4 		$27.4M Buy
53,715
+785
+1% +$382K 0.1% 234
2022
Q3 		$23.1M Buy
+52,930
New +$25.5M 0.1% 239

Other funds holding CHE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Natixis Advisors's CHE Position: Q1 2024 in Review

Natixis Advisors sold out of Chemed (CHE) in Q1 2024, closing a stake of 58,006 shares — an estimated $33.9M sold.

Natixis Advisors first reported a position in CHE in Q3 2022 and held it in 6 quarters. The position peaked at $40.1M in Q3 2023. 510 funds tracked by Wall St. Rank hold CHE as of Q1 2024.

  • Natixis Advisors reported no remaining Chemed position as of Q1 2024 after selling out during the quarter.
  • Natixis Advisors sold 58,006 Chemed shares in Q1 2024, an estimated $33.9M.
  • Natixis Advisors first reported a position in Chemed in Q3 2022 and held it in 6 quarters.
  • Natixis Advisors's Chemed position peaked at $40.1M in Q3 2023.
  • 510 funds tracked by Wall St. Rank held Chemed as of Q1 2024.

Based on Natixis Advisors's 13F filing for Q1 2024, filed 25 Apr 2024.